Impact of switching from ranibizumab to aflibercept on the number of intravitreous injection and follow up visit in wet AMD: results of real life ELU study

Impact of switching from ranibizumab to aflibercept on the number of intravitreous injection and follow up visit in wet AMD: results of real life ELU study

"AIM: To study if one of the two molecules could lead to a lower number of follow up visits and intra-vitreous injection (IVI) with the same efficacy. METHODS: ELU (or “elected” in French) study is a retrospective study conducted in real life in patients presenting suboptimal response after ra...

Full description

Bibliographic Details
Main Authors: Frederic Queguiner, Kristina Bezirganyan, Jean Christophe Courjaret, Laurence Curel, Guillaume Penaranda, Maud Righini Chossegros
Format: Article
Language:English
Published: Press of International Journal of Ophthalmology (IJO PRESS) 2020-02-01
Series:International Journal of Ophthalmology
Subjects:
wet age-related macular degeneration
anti-vegf
aflibercept
ranibizumab
follow up visit
intravitreal injection
visual acuity
Online Access:http://www.ijo.cn/en_publish/2020/2/20200208.pdf

Internet

http://www.ijo.cn/en_publish/2020/2/20200208.pdf

Similar Items